T2DM: type 2 diabetes mellitus Recent research has revealed that TMAO may be a risk factor for the onset and progression of atherosclerosis, along with food and gut microbiota both of which may play a role in the development of cardiovascular disease, including atherosclerosis [68, 69]
Your doctor will inject a small amount of an irritant, such as dextrose, into the affected area, causing a controlled inflammatory response
When the NLRP3 inflammasome is activated, it activates caspase-1, which then forms active forms of pro-inflammatory cytokines such as IL-1 and IL-18 [186]
Hematology/Oncology Clinics North America
#Pharma #ProductManagement #DrugDevelopment #Obesity #GLP1 #Orforglipron #Foundayo #HealthcareInnovation #PharmaceuticalIndustry #LifeSciences #MedicalAffairs #ClinicalResearch #MarketAccess #PatientCentricity #PharmaMarketing To view or add a comment, sign in Eli Lilly announced positive results from two additional Phase 3 trials of retatrutide, bringing the investigational obesity drug closer to FDA approval
A., Hammond-Kosack, K
